Skip to content

The Cascade Feasibility Pilot (Ileostomy)

The Cascade Feasibility Pilot (Ileostomy): Improving Care Processes for New Ileostomy Patients Using Continuous Remote Patient Monitoring and a Cascading Alert System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05048329
Enrollment
11
Registered
2021-09-17
Start date
2021-08-09
Completion date
2022-08-31
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy; Complications, Ileostomy - Stoma

Keywords

Ileostomy

Brief summary

Existing interventions including improving communication and self-care to improve readmission of patients undergoing high risk colorectal surgery involving new ileostomy formation has shown limited results. Our proposal is to deploy a wearable solution that predicts physiological perturbation with continuous remote patient monitoring and advanced machine learning algorithms which will be connected to structured, cascading, escalation pathways and care coordination involving home health nurses, colorectal and ostomy nurses, and colorectal surgeons, and has the potential to transform surgical management in the post-discharge period, where patients are the most vulnerable for readmission. This feasibility study will contribute to the understanding of post-discharge continuous remote monitoring of ileostomy patients, promote patient self-care, and has the potential of improving patient outcomes.

Detailed description

Colorectal surgery is a high-risk surgery that results in significant morbidity, and health care utilization in the form of readmission. Ileostomy creation is a significant risk factor in colorectal surgery rehospitalization. Effective continuous remote patient monitoring (CRPM) can reduce readmissions, but it has only been realized in select heart failure populations via invasive monitoring. The investigators will focus on colorectal CRPM in the elective, new ileostomy population through a structured cascading and escalating alert system. In this feasibility study, the investigators will use a wearable biosensor and collect ambulatory physiological data that are analyzed by machine learning algorithms, to generate personalized alerts of physiological perturbation in colorectal surgery patients in the post-discharge period. Alerts from this algorithm may be cascaded with other patient status data to inform management by the home health team via a structured protocol built into the electronic health record (EHR). The escalation pathway will engage home health nurses, colorectal care team nurses, ostomy nurses, and colorectal surgeons. The investigators will conduct surveys and semi-structured interviews with patients, and semi-structured interviews with providers, which will be used to evaluate the perceptions, acceptance, and experience of this CRPM solution.

Interventions

Continuous patient monitoring through non-invasive biosensors coupled with machine learning algorithms, with a structured escalation and communication pathway for home health providers and colorectal clinical team

Sponsors

Endeavor Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patient is inpatient admission at NorthShore University HealthSystem hospital * Patient underwent a new ileostomy formation at index hospitalization * Patient is at least 18 years of age * Patient is fluent in English * Patient agrees to protocol-required procedures * Patient discharges with NorthShore Home Health Service

Exclusion criteria

* Patient has cognitive or physical limitations that, in the investigator's opinion, limit the patient's ability to maintain patch device and phone * Patient has allergy to hydrocolloid adhesives * Patient has present skin damage preventing them from wearing a study device * Pregnancy * Patient discharge location is a Skilled Nursing Facility or other subacute facilities

Design outcomes

Primary

MeasureTime frameDescription
Attrition Rate30 days from patient discharge dateDrop out from study
Enrollment RateThrough study completion, an average of 30 days for each patientEnrollment rate for entire patient cohort

Secondary

MeasureTime frameDescription
30 Days Readmission30 days from patient discharge date30-day readmission to hospital
Number of Participants With Stool Regimen Escalation30 days from patient discharge dateFrequency of stool regimen escalation by providers

Countries

United States

Participant flow

Recruitment details

Recruitment was conducted at three NorthShore Hospitals from August 2021 and September 2022

Pre-assignment details

A total of 11 participants were enrolled in the study. One patient withdrew and one was a screen fail, resulting in a total of 9 participants who completed the study.

Participants by arm

ArmCount
Ileostomy Cohort
The study will include ten eligible patients into the cohort to conduct the study. Non-invasive continuous remote monitoring with structured escalation pathway: Continuous patient monitoring through non-invasive biosensors coupled with machine learning algorithms, with a structured escalation and communication pathway for home health providers and colorectal clinical team Affective Analysis of Participant Response to Continuous Remote Patient Monitoring: Surveys and interviews with enrolled participants
9
Total9

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyScreenfail1
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicIleostomy Cohort
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
3 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
7 Participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 11
other
Total, other adverse events
0 / 11
serious
Total, serious adverse events
0 / 11

Outcome results

Primary

Attrition Rate

Drop out from study

Time frame: 30 days from patient discharge date

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ileostomy CohortAttrition Rate2 Participants
Primary

Enrollment Rate

Enrollment rate for entire patient cohort

Time frame: Through study completion, an average of 30 days for each patient

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ileostomy CohortEnrollment Rate11 Participants
Secondary

30 Days Readmission

30-day readmission to hospital

Time frame: 30 days from patient discharge date

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ileostomy Cohort30 Days Readmission1 Participants
Secondary

Number of Participants With Stool Regimen Escalation

Frequency of stool regimen escalation by providers

Time frame: 30 days from patient discharge date

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Ileostomy CohortNumber of Participants With Stool Regimen Escalation2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026